Anti-cytokine therapy for prevention of atherosclerosis

被引:29
|
作者
Kirichenko, Tatiana V. [1 ,2 ]
Sobenin, Igor A. [2 ,3 ]
Nikolic, Dragana [4 ]
Rizzo, Manfredi [4 ,5 ]
Orekhov, Alexander N. [1 ,2 ]
机构
[1] Skolkovo Innovat Ctr, Inst Atherosclerosis Res, 4-1-207 Osennaya Str, Moscow 121609, Russia
[2] Inst Gen Pathol & Pathophysiol, 8 Baltiyskaya Str, Moscow 125315, Russia
[3] Russian Cardiol Res & Prod Complex, 15-A 3rd Cherepkovskaya Str, Moscow 121552, Russia
[4] Univ Palermo, Biomed Dept Internal Med & Med Specialties, 141 Via Vespro, I-90127 Palermo, Italy
[5] Euromediterranean Inst Sci & Technol, Via Emerico Amari 123, I-90139 Palermo, Italy
关键词
Atherosclerosis prevention; Anti-cytokine therapy; Inflammation; Herbal preparation; TUMOR-NECROSIS-FACTOR; INTIMA-MEDIA THICKNESS; C-REACTIVE PROTEIN; CORONARY-ARTERY-DISEASE; CARDIOVASCULAR-DISEASE; ANTIINFLAMMATORY THERAPIES; INFLAMMATORY CYTOKINES; MESSENGER-RNA; HEART-DISEASE; MACROPHAGE;
D O I
10.1016/j.phymed.2015.12.002
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Background: Currently a chronic inflammation is considered to be the one of the most important reasons of the atherosclerosis progression. A huge amount of researches over the past few decades are devoted to study the various mechanisms of inflammation in the development of atherosclerotic lesions. Purpose: To review current capabilities of anti-inflammatory therapy for the prevention and treatment of atherosclerosis and its clinical manifestations. Methods: Appropriate articles on inflammatory cytokines in atherosclerosis and anti-inflammatory prevention of atherosclerosis were searched in PubMed Database from their respective inceptions until October 2015. Sections: "The role of inflammatory cytokines in the development of atherosclerotic lesions" describes available data on the possible inflammatory mechanisms of the atherogenesis with a special attention to the role of cytokines. "Modern experience of anti-inflammatory therapy for the treatment of atherosclerosis" describes modern anti-inflammatory preparations with anti-atherosclerotic effect including natural preparations. In "the development of anti-inflammatory herbal preparation for atherosclerosis prevention" an algorithm is demonstrated that includes screening of anti-cytokine activity of different natural products, the development of the most effective combination and estimation of its effect in cell culture model, in animal model of the acute aseptic inflammation and in a pilot clinical trial. A natural preparation "Inflaminat" based on black elder berries (Sambucus nigra L), violet tricolor herb (Viola tricolor L.) and calendula flowers (Calendula officinalis L.) possessing anti-cytokine activity was developed using the designed algorithm. The results of the following 2-year double blind placebo-controlled clinical study show that "Inflaminat" reduces carotid IMT progression, i.e. has anti-atherosclerotic effect. Conclusion: Anti-cytokine therapy may be a promising direction in moderation of atherogenesis, especially when it begins on the early stages of subclinical atherosclerosis. The use of herbal preparations with anti-cytokine mechanism of action is the most perspective for timely prevention of atherosclerosis, as they have no significant side effects and can be prescribed for long-term administration. (C) 2015 Elsevier GmbH. All rights reserved.
引用
收藏
页码:1198 / 1210
页数:13
相关论文
共 50 条
  • [41] Histological remission of ulcerative colitis with combined anti-cytokine and cell therapy
    Knyazev, Oleg, V
    Khomeriki, Sergey G.
    Kagramanova, Anna, V
    Lishchinskaya, Albina A.
    Smirnova, Olga A.
    Noskova, Karina K.
    Parfenov, Asfold, I
    TERAPEVTICHESKII ARKHIV, 2021, 93 (12) : 1435 - 1442
  • [43] Anti-cytokine therapy for the treatment of graft-versus-host disease
    Jacobsohn, DA
    Vogelsang, GB
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (11) : 1195 - 1205
  • [44] Therapeutic applications of anti-cytokine strategies
    S Poole
    Molecular Psychiatry, 1997, 2 : 137 - 138
  • [45] Anti-cytokine antibodies for rheumatic diseases
    Atzeni, Fabiola
    Sarzi-Puttini, Piercarlo
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (11) : 1204 - 1211
  • [46] Anti-cytokine autoantibodies in autoimmune diseases
    Cappellano, Giuseppe
    Orilieri, Elisabetta
    Woldetsadik, Abiy D.
    Boggio, Elena
    Soluri, Maria F.
    Comi, Cristoforo
    Sblattero, Daniele
    Chiocchetti, Annalisa
    Dianzani, Umberto
    AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2012, 1 (02): : 136 - 146
  • [47] Anti-cytokine autoantibodies in postherpetic neuralgia
    Ahmad Bayat
    Peter D. Burbelo
    Sarah K. Browne
    Mark Quinlivan
    Bianca Martinez
    Steven M. Holland
    Asokumar Buvanendran
    Jeffrey S. Kroin
    Andrew J. Mannes
    Judith Breuer
    Jeffrey I. Cohen
    Michael J. Iadarola
    Journal of Translational Medicine, 13
  • [48] Targeted anti-cytokine therapies for osteoarthritis
    Chevalier, Xavier
    Mugnier, Benedicte
    Bouvenot, Gilles
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2006, 190 (07): : 1411 - 1420
  • [49] Anti-cytokine vaccination in autoimmune diseases
    Delavallee, Laure
    Duvallet, Emilie
    Semerano, Luca
    Assier, Eric
    Boissier, Marie-Christophe
    SWISS MEDICAL WEEKLY, 2010, 140 : 28 - 32
  • [50] Cytokine and anti-cytokine therapies for inflammatory bowel disease
    Ogata, H
    Hibi, T
    CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (14) : 1107 - 1113